Prescription Sleeping Pill Use Tied to Cancer

... San Diego, Calif. has found evidence that taking sleeping pills regularly can increase the risk of skin ... based on a compilation of studies involving sleeping pills and cancer, has just been published in the ... uncertain malignancy in the groups that took sleeping pills compared to none in the placebo groups. ...

Immtech Reports Fiscal Second Quarter 2008 Results

... oral drug candidate, in the Phase III African sleeping sickness trial. During the three-month period ... for pafuramidine to treat malaria and African sleeping sickness, added a new board member and a ... (PCP), malaria, and trypanosomiasis (African sleeping sickness or HAT), and a well-defined, expanding ...

Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials

... pafuramidine as an oral treatment for African sleeping sickness and, if it is approved, pafuramidine ... In addition to targeting African sleeping sickness and PCP, pafuramidine is also ... malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well defined, expanding library ...

Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial

... Tryanosomiasis (HAT), also know as African sleeping sickness. African sleeping sickness is a fatal, vector-borne parasitic ... effective oral treatment for first-stage African sleeping sickness. Carol Olson, MD, PhD, Immtech's Sr. ...

US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness

... significant need for new treatments for African sleeping sickness," stated Carol Olson, MD, PhD, Immtech's ... community clinics as well as at current African sleeping sickness treatment centers. Patients could ... and malaria. In addition to trials for African sleeping sickness, pafuramidine is currently in Phase III ...

Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases

... of efficacy against leishmaniasis and African sleeping sickness (trypanosomiasis). These parasites, ... can be lethal if untreated. About African sleeping Sickness (Trypanosomiasis). sleeping sickness is a parasitic disease in people and ...

Brain Stem Cells Can Be Awakened, Say Schepens Scientists

... found that removing these molecules (with a genetic tool) activated the sleeping stem cells. The team also found that astrocytes in the hippocampus ... of the two papers. The next step for the team will be to stimulate the sleeping stem cells in animals who are models of neurodegenerative disorders, such ...

Immtech Focusing on Other Infectious Disease Programs Following Discontinuation of Development of Pafuramidine

... that the potential risk associated with further treatment of African sleeping sickness patients outweighs the benefits of further development because ... the Data Safety Monitoring Board, the Governance Council for the African sleeping sickness grant for the PCP study. The US Food and Drug Administration and ...

General Wesley Clark Joins Immtech as Consulting Strategic Advisor

... (PCP), a severe form of fungal infection in the lungs, and African sleeping sickness. About Immtech Pharmaceuticals, Inc. Immtech Pharmaceuticals, ... for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting ...

Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases

... high-quality human ocular tissue for research, study, collaboration, and clinical advancements, as well as extensive space for on-site residence, sleeping quarters, and meetings/events. This marks an expansion of the current 35,000 square-foot Tampa Eye Bank facility, already the world's largest ...

HealthMedia and Aetna to Study Online Insomnia and Depression Interventions

... program will study the impact on prescription medication utilization. According to one study, Americans filled more than 35 million prescriptions for sleeping pills in 2004, spending $2.1 billion. Studies predict these costs to double by the end of the decade. Golinkoff confirmed that Aetna's prescription ...

Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder

... on Daily Activities in MDD Patients Total sleep time was increased in the Ambien CR group throughout the study. At Week eight, patients reporting sleeping an average of 101 minutes more than baseline compared to placebo-treated patients who reported sleeping an average 64 minutes more (P<0.0001). On ...

Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007

... "feels blue," clinical depression is a serious and often disabling condition that can significantly affect a person's work, family and school life, sleeping and eating habits, general health, and ability to enjoy life. Having depression is also a major risk factor for suicide; in addition, people ...

Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722

... "feels blue," clinical depression is a serious and often disabling condition that can significantly affect a person's work, family and school life, sleeping and eating habits, general health, and ability to enjoy life. Having depression is also a major risk factor for suicide; in addition, people ...

Immtech Announces Posting of Annual Shareholders Meeting Presentation

... diseases. Immtech has advanced clinical programs that include new treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting Hepatitis C, fungal infections, and bacterial infections. Immtech holds ...

Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day

... by joining the water-bearers processions or by coming to the Cyclorama for any period during the twenty-four hours of December 1. "People bring sleeping bags and spend the night at Medicine Wheel; dozens of artists add the gift of their art with dance, music, singing and spoken word within the ...

Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

... has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well-defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal infections, Hepatitis C and ...

Chinese SFDA Grants Immtech Fast Track Status

... Immtech has advanced clinical programs that include new oral treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting Hepatitis C, fungal infections, and bacterial infections. Immtech holds ...

Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms

... Immtech has advanced clinical programs that include new oral treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting fungal infections, Hepatitis C and other serious diseases. Immtech holds ...

Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo

... loss of interest or pleasure. -- Depressed mood -- Loss of interest or pleasure -- Changes in appetite or weight -- Changes in sleeping patterns -- Psychomotor agitation or retardation -- Fatigue or low energy -- Feeling worthless or guilty for no reason -- ...

New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder

... loss of interest or pleasure. -- Depressed mood -- Loss of interest or pleasure -- Changes in appetite or weight -- Changes in sleeping patterns -- Psychomotor agitation or retardation -- Fatigue or low energy -- Feeling worthless or guilty for no reason -- ...

Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia

... of subtypes of insomnia in the general population. -- According to a survey of 14,997 U.S. adults, 43.3% of respondents self-reported sleeping difficulties related to insomnia; compared to only 8.5% who met the more stringent Diagnostic and Statistic Manual of Mental ...